80 Chapter 3 Supplementary figure S5: Evaluation of MET immunoreactivity using a scatter plot in view of survival analysis. A through C. The scatter plot depicted under (A) – used to characterize MET immunoreactivity across cancer surfaces – reveals constant and variable membranous MET staining across cancer surfaces. The scatter plots depicted under (B & C) – used to examine the relation between the pattern of MET immunoreactivity and survival (green dot: alive; red dot: deceased) – reveal that the relative number of events (i.e. OS or DFS) within the clusters (dots within the circles) that depict uniform staining (negative or positive) is higher compared to the relative number of events outside them for both 5-year OS (B) and DFS (C). Kaplan-Meier curves and the No. of patients at risk. D. 5-year OS & E. 5-year DFS for all patients, stratified by MET staining pattern.
RkJQdWJsaXNoZXIy MTk4NDMw